ARTIVION INC (AORT) Stock Fundamental Analysis
NYSE:AORT - New York Stock Exchange, Inc. - US2289031005 - Common Stock - Currency: USD
Overall AORT gets a fundamental rating of 4 out of 10. We evaluated AORT against 188 industry peers in the Health Care Equipment & Supplies industry. AORT has an average financial health and profitability rating. While showing a medium growth rate, AORT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year AORT has reported negative net income.
In the past year AORT had a positive cash flow from operations.
In the past 5 years AORT always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: AORT reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of AORT (-2.70%) is better than 68.62% of its industry peers.
Looking at the Return On Equity, with a value of -7.26%, AORT is in the better half of the industry, outperforming 69.68% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 2.26%, AORT is in the better half of the industry, outperforming 69.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.7% | ||
| ROE | -7.26% | ||
| ROIC | 2.26% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AORT has a Operating Margin of 5.41%. This is in the better half of the industry: AORT outperforms 71.81% of its industry peers.
In the last couple of years the Operating Margin of AORT has grown nicely.
AORT's Gross Margin of 63.94% is fine compared to the rest of the industry. AORT outperforms 65.43% of its industry peers.
In the last couple of years the Gross Margin of AORT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.41% | ||
| PM (TTM) | N/A | ||
| GM | 63.94% |
OM growth 3Y31.35%
OM growth 5Y5.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AORT is destroying value.
Compared to 1 year ago, AORT has more shares outstanding
Compared to 5 years ago, AORT has more shares outstanding
The debt/assets ratio for AORT is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.30 indicates that AORT is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.30, AORT is doing good in the industry, outperforming 62.23% of the companies in the same industry.
A Debt/Equity ratio of 1.08 is on the high side and indicates that AORT has dependencies on debt financing.
The Debt to Equity ratio of AORT (1.08) is worse than 78.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.08 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.3 |
ROIC/WACC0.27
WACC8.5%
2.3 Liquidity
AORT has a Current Ratio of 5.53. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 5.53, AORT is doing good in the industry, outperforming 79.79% of the companies in the same industry.
A Quick Ratio of 3.95 indicates that AORT has no problem at all paying its short term obligations.
The Quick ratio of AORT (3.95) is better than 71.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.53 | ||
| Quick Ratio | 3.95 |
3. Growth
3.1 Past
AORT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.86%.
AORT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.94%.
The Revenue has been growing slightly by 7.06% on average over the past years.
EPS 1Y (TTM)-42.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-116.67%
Revenue 1Y (TTM)5.94%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%1.59%
3.2 Future
The Earnings Per Share is expected to grow by 61.12% on average over the next years. This is a very strong growth
AORT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.22% yearly.
EPS Next Y122.93%
EPS Next 2Y77.09%
EPS Next 3Y61.12%
EPS Next 5YN/A
Revenue Next Year9.01%
Revenue Next 2Y9.7%
Revenue Next 3Y10.22%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AORT. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 58.66 indicates a quite expensive valuation of AORT.
AORT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AORT is cheaper than 65.43% of the companies in the same industry.
AORT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.17, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 58.66 |
4.2 Price Multiples
AORT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AORT is cheaper than 70.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 33.35 |
4.3 Compensation for Growth
AORT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AORT's earnings are expected to grow with 61.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.09%
EPS Next 3Y61.12%
5. Dividend
5.1 Amount
No dividends for AORT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
28.66
+0.21 (+0.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners85.43%
Inst Owner ChangeN/A
Ins Owners5.47%
Ins Owner Change12.37%
Market Cap1.22B
Analysts86.67
Price Target32.98 (15.07%)
Short Float %11.52%
Short Ratio8.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-222.77%
Min EPS beat(2)-537.25%
Max EPS beat(2)91.71%
EPS beat(4)2
Avg EPS beat(4)-133.26%
Min EPS beat(4)-537.25%
Max EPS beat(4)91.71%
EPS beat(8)5
Avg EPS beat(8)-81.69%
EPS beat(12)8
Avg EPS beat(12)-43.69%
EPS beat(16)10
Avg EPS beat(16)-60.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.61%
Min Revenue beat(2)-5.37%
Max Revenue beat(2)2.16%
Revenue beat(4)1
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.16%
Revenue beat(8)5
Avg Revenue beat(8)0.88%
Revenue beat(12)7
Avg Revenue beat(12)0.57%
Revenue beat(16)10
Avg Revenue beat(16)6.83%
PT rev (1m)0%
PT rev (3m)-2.51%
EPS NQ rev (1m)-299.4%
EPS NQ rev (3m)-111.1%
EPS NY rev (1m)479.9%
EPS NY rev (3m)-37.23%
Revenue NQ rev (1m)0.37%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)0.87%
Revenue NY rev (3m)-0.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 58.66 | ||
| P/S | 3.14 | ||
| P/FCF | N/A | ||
| P/OCF | 113.57 | ||
| P/B | 4.16 | ||
| P/tB | N/A | ||
| EV/EBITDA | 33.35 |
EPS(TTM)-0.5
EYN/A
EPS(NY)0.49
Fwd EY1.7%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.25
OCFY0.88%
SpS9.14
BVpS6.89
TBVpS-2.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.7% | ||
| ROE | -7.26% | ||
| ROCE | 2.86% | ||
| ROIC | 2.26% | ||
| ROICexc | 2.38% | ||
| ROICexgc | 5.55% | ||
| OM | 5.41% | ||
| PM (TTM) | N/A | ||
| GM | 63.94% | ||
| FCFM | N/A |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.89%
ROICexcg growth 5Y4.3%
ROICexc growth 3Y45.07%
ROICexc growth 5Y7.68%
OM growth 3Y31.35%
OM growth 5Y5.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score4
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.08 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.08 | ||
| Cap/Depr | 47.24% | ||
| Cap/Sales | 2.88% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 24.03% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.53 | ||
| Quick Ratio | 3.95 | ||
| Altman-Z | 2.3 |
F-Score4
WACC8.5%
ROIC/WACC0.27
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-116.67%
EPS Next Y122.93%
EPS Next 2Y77.09%
EPS Next 3Y61.12%
EPS Next 5YN/A
Revenue 1Y (TTM)5.94%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%1.59%
Revenue Next Year9.01%
Revenue Next 2Y9.7%
Revenue Next 3Y10.22%
Revenue Next 5YN/A
EBIT growth 1Y-9.27%
EBIT growth 3Y43.36%
EBIT growth 5Y12.95%
EBIT Next Year107.33%
EBIT Next 3Y42.09%
EBIT Next 5YN/A
FCF growth 1Y97.95%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y200.63%
OCF growth 3YN/A
OCF growth 5Y7.04%